The DITRAP consortium will come together in Barcelona on 3–4 September 2026 for the project’s kick-off meeting, hosted by RemAb, marking the start of its collaborative work. Over two days, the partners will align on the project vision, scientific background, management and governance, and activities across all work packages. These include manufacturing and regulatory preparation, AI-driven patient stratification, clinical trial implementation, immunological and clinical data analysis, health technology assessment, communication and exploitation, and ethics. The programme will also provide dedicated opportunities for networking and discussion, helping to establish a shared understanding of the project’s priorities, responsibilities, and next steps.
